4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-006335
Chief Scientific Officer sold 1,698 shares at $9.00 ($15,282)
- Chief Scientific Officer acquired 1,698 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2025-03-24 | Option exercise 10b5-1 | +1,698 | $6.32 | $10,731 | 1,281,222 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2025-03-24 | Sale 10b5-1 | −1,698 | $9.00 | $15,282 | 1,279,524 | D: show line 2 in the form |
| Open-market sales · 1,698 sh · avg $9.00 · $15,282 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2025-03-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,698 | 68,412 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…